First, surgical resection specimens from 38 glioma patients who are receiving neoadjuvant chemotherapy were analyzed for the correlations between CTGF expression and glioma grades through immunohistochemical (IHC) staining and qPCR analysis. This evidence concerns the gene CCN2 and central nervous system cancer.